
    
      60 patients with stage Ⅲb～Ⅳ NSCLC will be randomly divided into group A（receive D-CIK
      treatment and chemotherapy) or group B（just receive chemotherapy),and the randomize ratio
      will be 1:1. Patients in group A will receive 3 cycles of D-CIK treatment (every 1 months)
      and 4 cycles of chemotherapy (every 2 weeks).Patients in group B will receive only 4 cycles
      chemotherapy（every 2 weeks).
    
  